量化式目标锻炼联合全程精细化营养管理在血液病化疗患者中的应用效果

朱丽; 唐海龙; 胡蕾; 赵引丽; 郭丝锦

doi:10.16766/j.cnki.issn.1674-4152.003235

量化式目标锻炼联合全程精细化营养管理在血液病化疗患者中的应用效果

doi: 10.16766/j.cnki.issn.1674-4152.003235

1.
空军军医大学第一附属医院血液肿瘤科，陕西西安 710032
2.
空军军医大学第一附属医院甲乳血管外科

基金项目:

国家自然科学基金项目 82100218

详细信息

通讯作者:
郭丝锦，E-mail：nabiboymo@163.com

中图分类号: R55 R453 R459.3
计量
- 文章访问数: 94
- HTML全文浏览量: 37
- PDF下载量: 7
- 被引次数: 0
出版历程
- 收稿日期: 2022-11-17
- 网络出版日期: 2024-01-13

Application of quantitative goal exercise combined with whole process refined nutrition management in patients with hematological disease chemotherapy

1.
Department of Hematology and Oncology, First Affiliated Hospital of Air Force Military Medical University, Xi' an, Shaanxi 710032, China

摘要

摘要: 目的探讨量化式目标锻炼(QGE)联合全程精细化营养管理(WP-RNM)对血液病化疗患者临床效果的影响，为提高血液病患者化疗后康复管理质量提供依据。方法选取空军军医大学第一附属医院2019年2月—2021年6月收治的血液病化疗患者126例，采用随机数表法分为观察组和对照组各63例。对照组采用常规干预，观察组在常规干预的基础上加用QGE联合WP-RNM干预方案。比较2组干预前后的营养状况、免疫功能及生活质量变化。结果观察组干预后血红蛋白(Hb)、血浆前白蛋白(PAB)、白蛋白(ALB)、转铁蛋白(TRF)均明显高于对照组(均P＜0.001)，主观整体营养状况评估量表(PG-SGA)评分明显低于对照组[(1.92±0.72)分vs.(4.26±0.81)分，t=17.138，P＜0.01]；观察组干预后肿瘤患者生活质量自评量表-30(QLQ-C30)各评分均明显低于对照组(均P＜0.001)；观察组干预后血清IgG抗体(IgG)、IgA抗体(IgA)、IgM抗体(IgM)、CD3⁺T细胞百分比、CD4⁺T细胞百分比均明显高于对照组(t=28.857、6.683、9.191、20.013、12.798，均P＜0.01)。结论 QGE联合WP-RNM能有效提高血液病化疗患者的营养摄入量和免疫功能，改善患者的生活质量。
- 血液病 /
- 化疗 /
- 量化式目标锻炼 /
- 全程精细化营养管理
Abstract: Objective To explore the effect of quantitative targeted exercise (QGE) combined with whole process refined nutrition management (WP-RNM) on the clinical results of patients with hematologic diseases undergoing chemotherapy, and to provide evidence for improving the quality of rehabilitation management of patients with hematologic diseases after chemotherapy. Methods A total of 126 patients with hematologic diseases treated with chemotherapy in First Affiliated Hospital of Air Force Military Medical University from February 2019 to June 2021 were selected and randomly divided into observation group and control group with 63 patients in each group by random number table sampling method. The control group was treated with routine intervention, and the observation group was treated with QGE combined WP-RNM intervention program on the basis of routine intervention. The nutritional status, immune function and life quality of the two groups were compared before and after intervention. Result After intervention, the scores of hemoglobin (Hb), plasma prealbumin (PAB), albumin (Alb), transferrin (TRF) and scored patient-generated subjective global assessment(PG-SGA) in the observation group were significantly higher than those in the control group (all P<0.001). The PG-SGA score was significantly lower than that of the control group [(1.92±0.72) points vs. (4.26±0.81) points, t=17.138, P<0.01]. After intervention, the scores of quality of life questionnaire-C30 (QLQ-C30) in the observation group were significantly lower than those in the control group (all P<0.001). After intervention, serum IgG antibody (IgG), IgA antibody (IgA), IgM antibody (IgM), percentage of CD3⁺T cells and CD4⁺T cells in the observation group were significantly higher than those in the control group (t-values: 28.857, 6.683, 9.191, 20.013 and 12.798, respectively, all P<0.01). Conclusion QGE combined with WP-RNM can effectively improve the nutritional intake and immune function of patients with hematological diseases and improve the quality of life of patients.
- Blood disease /
- Chemotherapy /
- Quantitative goal exercise combined /
- Whole process refined nutrition management

HTML全文

表 1 2组血液病化疗患者临床资料比较

Table 1. Comparison of clinical data between two groups of chemotherapy patients with hematologic diseases

组别	例数	性别 (男性/女性，例)	年龄(x±s，岁)	疾病类型(例)
组别	例数	性别 (男性/女性，例)	年龄(x±s，岁)	白血病	淋巴瘤	骨髓异常综合征
观察组	63	35/28	51.65±2.71	28	21	14
对照组	63	37/26	51.78±2.79	29	24	10
统计量		0.130^a	0.265^b	0.884^a
P值		0.719	0.791	0.643
注：^a为χ²值，^b为t值。

下载: 导出CSV

表 2 2组血液病化疗患者干预前后营养状况比较(x±s)

Table 2. Comparison of nutritional status between two groups of chemotherapy patients with hematologic diseases before and after intervention (x±s)

组别	例数	Hb(g/L)		PAB(g/L)		ALB(g/L)		TRF(mg/dL)		PG-SGA评分(分)
组别	例数	干预前	干预后	干预前	干预后	干预前	干预后	干预前	干预后	干预前	干预后
观察组	63	102.21±9.72	142.12±11.16^a	127.68±9.65	295.61±13.35^a	26.72±2.79	36.63±2.89^a	152.81±12.73	268.81±14.95^a	8.73±0.85	1.92±0.72^a
对照组	63	101.87±8.92	115.62±11.23^a	128.82±8.93	232.52±12.58^a	26.87±2.85	31.75±2.93^a	149.95±12.71	215.69±13.75^a	8.83±0.26	4.26±0.81^a
t值		0.205	13.285	0.688	27.299	0.299	9.412	1.262	20.758	0.893	17.138
P值		0.838	＜0.001	0.493	＜0.001	0.765	＜0.001	0.209	＜0.001	0.375	＜0.001
注：与同组干预前比较，^aP＜0.05。

下载: 导出CSV

表 3 2组血液病化疗患者干预前后QLQ-C30各项目评分比较(x±s，分)

Table 3. Comparison of QLQ-C30 scores between two groups of chemotherapy patients with hematologic diseases before and after intervention (x±s, points)

组别	例数	食欲质量		睡眠质量		日常生活质量		精神质量		家庭理解与配合程度
组别	例数	干预前	干预后	干预前	干预后	干预前	干预后	干预前	干预后	干预前	干预后
观察组	63	4.31±0.25	1.25±0.15^a	4.33±0.52	1.42±0.36^a	4.11±0.72	1.35±0.62^a	4.28±0.69	1.35±0.27^a	4.26±0.62	1.27±0.31^a
对照组	63	4.33±0.18	2.76±0.16^a	4.35±0.65	2.62±0.58^a	4.15±0.78	3.12±0.85^a	4.24±0.76	3.13±0.26^a	4.32±0.67	3.13±0.16^a
t值		0.515	54.648	0.191	13.953	0.299	13.353	0.309	37.692	0.522	42.319
P值		0.608	＜0.001	0.849	＜0.001	0.765	＜0.001	0.758	＜0.001	0.603	＜0.001
注：与同组干预前比较，^aP＜0.001。

下载: 导出CSV

表 4 2组血液病化疗患者干预前后免疫指标比较(x±s)

Table 4. Comparison of immune indexes between two groups of chemotherapy patients with hematologic diseases before and after intervention (x±s)

组别	例数	IgG(g/L)		IgA(g/L)		IgM(g/L)		CD3⁺(%)		CD4⁺(%)
组别	例数	干预前	干预后	干预前	干预后	干预前	干预后	干预前	干预后	干预前	干预后
观察组	63	8.72±0.13	8.68±0.18	3.19±0.65	3.15±0.72	1.65±0.25	1.59±0.52	56.69±2.78	56.12±2.95	34.71±2.58	34.27±2.82
对照组	63	8.69±0.17	7.56±0.25^a	3.16±0.73	2.35±0.62^a	1.63±0.31	0.96±0.16^a	56.13±0.75	45.83±2.82^a	34.97±2.84	27.69±2.95^a
t值		1.113	28.857	0.244	6.683	0.399	9.191	1.544	20.013	0.538	12.798
P值		0.268	＜0.001	0.808	＜0.001	0.691	＜0.001	0.127	＜0.001	0.592	＜0.001
注：与同组干预前比较，^aP＜0.001。

下载: 导出CSV

参考文献(16)

[1]	NASIR I A, MEDUGU J T, DANGANA A. Human parvovirus B19-associated hematopathy in HIV disease: need for clinicopathological revisit[J]. J Biomed Res, 2017, 21(32): 3052-3059.
[2]	徐钦, 王婷婷, 曹阳. 营养支持对白血病化疗患者营养状况及不良反应的影响[J]. 临床医药文献电子杂志, 2019, 6(76): 48, 50. XU Q, WANG T T, CAO Y. Effects of nutritional support on nutritional status and adverse reactions in patients with leukemia chemotherapy[J]. Electro J Clin Med Liter, 2019, 6(76): 48, 50.
[3]	王晖, 李博玲, 周伟, 等. 参麦注射液对白血病化疗患者不良反应和免疫功能的影响[J]. 陕西中医, 2017, 38(10): 1441-1442. doi: 10.3969/j.issn.1000-7369.2017.10.061 WANG H, LI B L, ZHOU W, et al. Effects of Shenmai Injection on adverse reactions and immune function in patients with leukemia chemotherapy[J]. Shaanxi Chin Med, 2017, 38(10): 1441-1442. doi: 10.3969/j.issn.1000-7369.2017.10.061
[4]	刘俊, 彭浩, 许哲源, 等. 量化式目标锻炼对胸腔镜肺叶切除术后患者快速康复的影响[J]. 临床研究, 2020, 28(7): 149-150. LIU J, PENG H, XU Z Y, et al. Effect of quantitative target exercise on rapid recovery of patients after thoracoscopic lobectomy[J]. J Clin Invest, 2020, 28(7): 149-150.
[5]	王倩, 江玥, 李雨芳, 等. 食管癌患者微创术后应用量化式目标锻炼对康复速度和质量的影响[J]. 中国社区医师, 2019, 35(16): 166, 168. WANG Q, JIANG Y, LI Y F, et al. Effects of quantitative target exercise on the speed and quality of rehabilitation after minimally invasive surgery for patients with esophageal cancer[J]. Chin Commu Dr, 2019, 35(16): 166, 168.
[6]	CHEN J, YANG W, GONG Z. Revolutionary changes in salvage treatment for Hodgkin lymphoma: toward a chemotherapy-free future[J]. Ann Transl Med, 2018, 6(11): 237-243. doi: 10.21037/atm.2018.05.39
[7]	WIEGERT E V M, PADILHA P C, WAFERREIRA P. Performance of patient-generated subjective global assessment (PG-SGA) in patients with advanced cancer in palliative care[J]. Nutr Clin Pract, 2017, 32(5): 675-681. doi: 10.1177/0884533617725071
[8]	KESSEL K A, VOGEL M M, ALLES A, et al. Mobile App delivery of the EORTC QLQ-C30 questionnaire to assess health-related quality of life in oncological patients: usability study[J]. JMIR M health Uhealth, 2018, 6(2): e45. DOI: 10.2196/mhealth.9486.
[9]	DOMBRET H, ITZYKSON R. How and when to decide between epigenetic therapy and chemotherapy in patients with AML[J]. Hematology Am Soc Hematol Educ Program, 2017, 2017(1): 45-53. doi: 10.1182/asheducation-2017.1.45
[10]	田磊, 王继军, 景红梅. 恶性血液病患者合并血流感染的临床和病原学特征[J]. 中国感染与化疗杂志, 2017, 17(5): 504-508. TIAN L, WANG J J, JING H M. Clinical and etiological characteristics of patients with hematologic malignancies complicated with bloodstream infection[J]. Chin J Infect and Chemoth, 2017, 17(5): 504-508.
[11]	郭敏, 吴涛, 白海, 等. 血液病患者异基因造血干细胞移植相关感染的临床特征及预后[J]. 中华血液学杂志, 2019, 40(1): 69-72. GUO M, WU T, BAI H, et al. Clinical features and prognosis of allogeneic hematopoietic stem cell graft-associated infections in patients with hematological diseases[J]. Chin J Hematol, 2019, 40(1): 69-72.
[12]	谷金玲, 芮炳峰, 龚太乾, 等. 量化式目标锻炼对食管癌患者微创术后快速康复的效果观察[J]. 中华全科医学, 2019, 17(3): 504-507. doi: 10.16766/j.cnki.issn.1674-4152.000719 GU J L, RUI B F, GONG T Q, et al. Effect of quantitative target exercise on rapid rehabilitation of patients with esophageal cancer after minimally invasive surgery[J]. Chin J Gen Pract, 2019, 17(3): 504-507. doi: 10.16766/j.cnki.issn.1674-4152.000719
[13]	中国侵袭性真菌感染工作组. 血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第五次修订版)[J]. 中华内科杂志, 2017, 56(6): 453-459. doi: 10.3760/cma.j.issn.0578-1426.2017.06.015 Chinese Working Group on invasive fungal Infections. Diagnostic criteria and treatment principles for invasive mycosis in patients with hematological diseases/malignancies (5th Revised Edition)[J]. Chin J Intern Med, 2017, 56(6): 453-459. doi: 10.3760/cma.j.issn.0578-1426.2017.06.015
[14]	薛志芳, 武雪亮, 王丽, 等. 全程精细化营养管理对老年食管癌同步放化疗患者营养状况、免疫功能及生活质量的影响[J]. 中国老年学杂志, 2019, 39(6): 1331-1334. doi: 10.3969/j.issn.1005-9202.2019.06.018 XUE Z F, WU X L, WANG L, et al. Effects of refined nutrition management on nutritional status, immune function and quality of life in elderly patients with concurrent radiotherapy and chemotherapy for esophageal cancer[J]. Chin J Gerontol, 2019, 39(6): 1331-1334. doi: 10.3969/j.issn.1005-9202.2019.06.018
[15]	刘力婕, 武雪亮, 王玉佳, 等. 主观全面评估营养筛查对结肠癌术后并发症的预测[J]. 实用医学杂志, 2018, 34(25): 2560-2563. LIU L J, WU X L, WANG Y J, et al. Subjective comprehensive assessment of nutritional screening in predicting postoperative complications of colon cancer[J]. J Pract Med, 2018, 34(25): 2560-2563.
[16]	SONTHALIA S, ARORA R, ABHISHEK A. Trastuzumab-docetaxel combination chemotherapy induced severe onychopathy[J]. Indian Dermatol Online J, 2017, 8(3): 222-223. doi: 10.4103/idoj.IDOJ_485_15